These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25308356)

  • 1. Efficacy of ursodeoxycholic acid as an adjuvant treatment to prevent acute cellular rejection after liver transplantation: a meta-analysis of randomized controlled trials.
    Deng YL; Xiong XZ; Cheng NS
    Hepatobiliary Pancreat Dis Int; 2014 Oct; 13(5):464-73. PubMed ID: 25308356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective, randomized, double-blind trial evaluating the efficacy of ursodeoxycholic acid in prevention of liver transplant rejection.
    Fleckenstein JF; Paredes M; Thuluvath PJ
    Liver Transpl Surg; 1998 Jul; 4(4):276-9. PubMed ID: 9649640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials.
    Shi J; Wu C; Lin Y; Chen YX; Zhu L; Xie WF
    Am J Gastroenterol; 2006 Jul; 101(7):1529-38. PubMed ID: 16863557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acids for liver-transplanted patients.
    Poropat G; Giljaca V; Stimac D; Gluud C
    Cochrane Database Syst Rev; 2010 Mar; (3):CD005442. PubMed ID: 20238339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acids for liver-transplanted patients.
    Chen W; Gluud C
    Cochrane Database Syst Rev; 2005 Jul; (3):CD005442. PubMed ID: 16034975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursodeoxycholic acid for primary biliary cirrhosis.
    Gong Y; Huang ZB; Christensen E; Gluud C
    Cochrane Database Syst Rev; 2008 Jul; (3):CD000551. PubMed ID: 18677775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid.
    Assy N; Adams PC; Myers P; Simon V; Minuk GY; Wall W; Ghent CN
    Transplantation; 2007 Jun; 83(12):1571-6. PubMed ID: 17589339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does prophylactic ursodeoxycholic acid treatment of liver transplant patients prevent acute rejection?
    Keiding S
    Hepatology; 1998 Jun; 27(6):1748-9. PubMed ID: 9620354
    [No Abstract]   [Full Text] [Related]  

  • 9. Ursodeoxycholic acid for primary biliary cirrhosis.
    Gluud C; Christensen E
    Cochrane Database Syst Rev; 2002; (1):CD000551. PubMed ID: 11869580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant treatment with ursodeoxycholic acid reduces acute rejection after liver transplantation.
    Friman S; Persson H; Scherstén T; Svanvik J; Karlberg I
    Transpl Int; 1992; 5 Suppl 1():S187-9. PubMed ID: 14621771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursodeoxycholic Acid Decreases Incidence of Primary Biliary Cholangitis and Biliary Complications After Liver Transplantation: A Meta-Analysis.
    Pedersen MR; Greenan G; Arora S; Murali AR; Mayo MJ
    Liver Transpl; 2021 Jun; 27(6):866-875. PubMed ID: 33185320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized clinical trial of ursodeoxycholic acid as adjuvant treatment to prevent liver transplant rejection.
    Barnes D; Talenti D; Cammell G; Goormastic M; Farquhar L; Henderson M; Vogt D; Mayes J; Westveer MK; Carey W
    Hepatology; 1997 Oct; 26(4):853-7. PubMed ID: 9328304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that ursodeoxycholic acid prevents steroid-resistant rejection in adult liver transplantation.
    Clavien PA; Sharara AI; Camargo CA; Harland RC; Fitz JG
    Clin Transplant; 1996 Dec; 10(6 Pt 2):658-62. PubMed ID: 8996761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of ursodeoxycholic acid to prevent acute cellular rejection after liver transplantation.
    Pageaux GP; Blanc P; Perrigault PF; Navarro F; Fabre JM; Souche B; Domergue J; Larrey D; Michel H
    J Hepatol; 1995 Aug; 23(2):119-22. PubMed ID: 7499781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis.
    Zhang Y; Li S; He L; Wang F; Chen K; Li J; Liu T; Zheng Y; Wang J; Lu W; Zhou Y; Yin Q; Xia Y; Zhou Y; Lu J; Guo C
    Drug Des Devel Ther; 2015; 9():2757-66. PubMed ID: 26045661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis.
    Uy MC; Talingdan-Te MC; Espinosa WZ; Daez ML; Ong JP
    Obes Surg; 2008 Dec; 18(12):1532-8. PubMed ID: 18574646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urosdeoxycholic acid in primary sclerosing cholangitis: a meta-analysis and systematic review.
    Othman MO; Dunkelberg J; Roy PK
    Arab J Gastroenterol; 2012 Sep; 13(3):103-10. PubMed ID: 23122450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis.
    Heathcote EJ; Stone J; Cauch-Dudek K; Poupon R; Chazouilleres O; Lindor KD; Petz J; Dickson ER; Poupon RE
    Liver Transpl Surg; 1999 Jul; 5(4):269-74. PubMed ID: 10388499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis.
    Triantos CK; Koukias NM; Nikolopoulou VN; Burroughs AK
    Aliment Pharmacol Ther; 2011 Oct; 34(8):901-10. PubMed ID: 21883323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid after common bile duct stones removal for prevention of recurrence: A systematic review and meta-analysis of randomized controlled trials.
    Chen X; Yan XR; Zhang LP
    Medicine (Baltimore); 2018 Nov; 97(45):e13086. PubMed ID: 30407311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.